Is the NIHSS certification process too lenient?

Cerebrovascular Diseases

Volumn 27, Issue 5, 2009, Pages 426-432

  Hills, Nancy K ^a   Josephson, S Andrew ^a   Lyden, Patrick D ^b,c   Johnston, S Claiborne ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

NIH Stroke Scale, reliability; Scoring the NIHSS certification test; Stroke

Indexed keywords

ARTICLE; CERTIFICATION; CLINICAL PRACTICE; CONSENSUS; DATA ANALYSIS; HEALTH CARE ORGANIZATION; HUMAN; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PRIORITY JOURNAL; SCORING SYSTEM; TASK PERFORMANCE; VIDEORECORDING;

CERTIFICATION; CLINICAL COMPETENCE; DIAGNOSTIC TESTS, ROUTINE; EDUCATION; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; STROKE; UNITED STATES;

EID: 62349103053     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000209237     Document Type: Article

References (29)

1. Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V, et al: Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989;20:864-870.
2. Muir KW, Weir CJ, Murray GD, Povey C, Lees KR: Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke 1996;27:1817-1820.
3. Goldstein LB, Bertels C, Davis JN: Interrater reliability of the NIH Stroke Scale. Arch Neurol 1989;46:660-662.
4. Albanese MA, Clarke WR, Adams HP Jr, Woolson RF: Ensuringreliability of outcome measures in multicenter clinical trials of treatments for acute ischemic stroke. The program developed for the trial of ORG 10172 in acute stroke treatment (TOAST). Stroke 1994;25:1746-1751.
5. Josephson SA, Hills NK, Johnston SC: NIH Stroke Scale reliability in ratings from a large sample of clinicians. Cerebrovasc Dis 2006; 22:389-395.
6. Lyden P, Raman R, Liu L, Grotta J, Broderick J, Olson S, Shaw S, Spilker J, Meyer B, Emr M, Warren M, Marler J: NIHSS training and certification using a new digital video disk is reliable. Stroke 2005;36:2446-2449.
7. NINDS rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. NEnglJ Med 1995;333:1581-1587.
8. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F: Intra-arterial pro-urokinase for acute ischemic stroke. The PRO ACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999;282:2003-2011.
9. IMS II Trial Investigators: The Interventional Management of Stroke (IMS) II Study. Stroke 2007;38:2127-2135.
10. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S: Recombi-nant tissue-type plasminogen activator (al-teplase) for ischemic stroke 3-5 hours after symptom onset. The ATLANTIS study: a randomized controlled trial. Alteplase thrombolysis for acute noninterventional therapy in ischemic stroke. JAMA 1999;282: 2019-2026.
11. Clark WM, Williams BJ, Selzer KA, Zweifler RM, Sabounjian LA, Gammans RE: A randomized efficacy trial of citicoline in patients with acute ischemic stroke. Stroke 1999;30:2592-2597.
12. Davis SM, Lees KR, Albers GW, Diener HC, Markabi S, Karlsson G, Norris J: Selfotel in acute ischemic stroke: possible neurotoxic effects of an NMDA antagonist. Stroke 2000; 31:347-354.
13. Del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M: PRO ACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PRO-ACT investigators. Prolyse in acute cerebral thromboembolism. Stroke 1998;29:4-11.
14. Grotta J: Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group. Stroke 1997;28:2338-2346.
15. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH, et al: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274: 1017-1025.
16. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P: Randomised double-blind, placebo-controlled trial of thrombo-lytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study investigators. Lancet 1998;352:1245-1251.
17. Johnston KC, Connors AF Jr, Wagner DP, Knaus WA, Wang X, Haley EC Jr: A predictive risk model for outcomes of ischemic stroke. Stroke 2000;31:448-455.
18. Schlegel D, Kolb SJ, Luciano JM, Tovar JM, Cucchiara BL, Liebeskind DS, Kasner SE: Utility of the NIH Stroke Scale as a predictor of hospital disposition. Stroke 2003;34:134-137.
19. Schlegel DJ, Tanne D, Demchuk AM, Levine SR, Kasner SE: Prediction of hospital disposition after thrombolysis for acute ischemic stroke usingthe National Institutes of Health Stroke Scale. Arch Neurol 2004;61:1061-1064.
20. Lyden P, Brott T, Tilley B, Welch KM, Mascha EJ, Levine S, Haley EC, Grotta J, Marler J: Improved reliability of the NIH Stroke Scale using video training. NINDS tPA Stroke Study Group. Stroke 1994;25:2220-2226.
21. American Stroke Association: NIH Stroke Scale training online, 2007.
22. National Stroke Association: NIH Stroke Scale, 2007.
23. Ende J: Feedback in clinical medical education. JAMA 1983;250:777-781.
24. Knowles M, Holton E, Swanson R: The Adult Learner. Houston/TX, Gulf Publishing, 1998.
25. Wood BP: Feedback: a key feature of medical training. Radiology 2000;215:17-19.
26. Kasner SE: Clinical interpretation and use of stroke scales. Lancet Neurol 2006;5:603-612.
27. Lyden PD, Lu M, Levine SR, Brott TG, Broderick J: A modified National Institutes of Health Stroke Scale for use in stroke clinical trials: preliminary reliability and validity. Stroke 2001;32:1310-1317.
28. Quinn T J, Lees KR, Hardemark HG, Dawson J, Walters MR: Initial experience of a digital training resource for modified Rankin scale assessment in clinical trials. Stroke 2007;38: 2257-2261.
29. Quinn TJ, Dawson J, Walters MR, Lees KR: Variability in modified Rankin scoring across a large cohort of international observers. Stroke 2008;39:2975-2979.